Science Explorer Back to mapMap
Discussion
Researcher · Indiana Cancer Consortium · United States

Luke Paul Akard

Luke Paul Akard publishes mostly in Hematology, Genetics and Oncology, on topics such as Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Hematopoietic Stem Cell Transplantation.

OpenAlex
World rank
#3,316,347
of 7,710,434 ranked researchers
Rank in United States
#936,567
of 1,627,098
Works
106
Citations
2.1k
Citations per work
19.6
h-index
26
i10-index 46Top 16% in Hematology
Luke Paul Akard

What does Luke Paul Akard research?

Luke Paul Akard's work is mostly in Medicine (62%), Immunology and Microbiology (7%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 66 works · 61.8% of their workMedicine: 66 works · 61.8% of their workHematology: 30 works · 28.6% of their workGenetics: 15 works · 14.0% of their workOncology: 13 works · 12.7% of their workPublic Health, Environmental and Occupational Health: 7 works · 6.5% of their workEverything else: 26 works · 24.9% of their workLife Sciences: 14 works · 13.3% of their workImmunology and Microbiology: 8 works · 7.5% of their workImmunology: 8 works · 7.5% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 5.8% of their workMolecular Biology: 6 works · 5.8% of their workTHEIR WORKLuke Paul Akard106works
Life Sciences13%Health Sciences62%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine6661.8%
  2. Everything else2624.9%
    1. Immunology and Microbiology87.5%
    2. Biochemistry, Genetics and Molecular Biology65.8%
  1. 1Hematology29% of their works
  2. 2Genetics14% of their works
  3. 3Oncology13% of their works
  4. 4Immunology8% of their works
  5. 5Public Health, Environmental and Occupational Health6% of their works
  6. 6Molecular Biology6% of their works

Research topics

Which keywords describe Luke Paul Akard's research?

The keywords of their largest research topics: Prognostic Factors, BCR-ABL, Imatinib, Hematopoietic Stem Cells, Chronic Lymphocytic Leukemia, Genomic Aberrations, Bone Marrow Niche and Graft-versus-Host Disease.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Prognostic Factors663 topics
  2. BCR-ABL421 topic
  3. Imatinib421 topic
  4. Hematopoietic Stem Cells392 topics
  5. Chronic Lymphocytic Leukemia341 topic
  6. Genomic Aberrations341 topic
  7. Bone Marrow Niche241 topic
  8. Graft-versus-Host Disease241 topic
  9. Acute Lymphoblastic Leukemia171 topic
  10. Childhood Cancer171 topic
  11. AML151 topic
  12. Acute Myeloid Leukemia151 topic
  13. Antimicrobial Agents131 topic
  14. Febrile Neutropenia131 topic
  15. Fusion Genes111 topic
  16. Hypereosinophilic Syndrome111 topic
  17. CAR T Cells91 topic
  18. Chimeric Antigen Receptor91 topic

Where does Luke Paul Akard work?

Luke Paul Akard's main affiliation in the publication record is Indiana Cancer Consortium, United States.

How many publications and citations does Luke Paul Akard have?

OpenAlex counts 106 works and 2,079 citations for Luke Paul Akard, an h-index of 26, ranking #3,316,347 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Luke Paul Akard. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.